Skip to main content
. 2025 Jan 21;31(3):95207. doi: 10.3748/wjg.v31.i3.95207

Figure 3.

Figure 3

Identification of mRNA candidates. A: Diagram representing the study design; B: Bubble plots of enriched GSEA terms in HepG2 cells; C: SNU449 cells treated with Sorafenib 24 hours. Bubble size is representative of gene count and color is representative of the normalized enrichment score; D: Heatmap of selected mRNAs in HepG2 and SNU449 cells.